Gabriele Ghisleni

Dr. Gabriele Ghisleni

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
GGGabriele Ghisleni
Gabriele Ghisleni
KCKatiucia M. Capiotti
Katiucia M. Capiotti
RSRosane S. Da Silva
Rosane S. Da Silva
JOJean P. Oses
Jean P. Oses
APAngelo Piato
Angelo Piato
CBCarla Denise Bonan
Carla Denise Bonan

1 February 2014 in European Journal of Pharmacology
Verified
Journal Article
Closed access
MGMarta Gazal
Marta Gazal
MVMatheus R. Valente
Matheus R. Valente
BABruna A. Acosta
Bruna A. Acosta
FKFernanda N. Kaufmann
Fernanda N. Kaufmann
EBElizandra Braganhol
Elizandra Braganhol
MKManuella P Kaster
Manuella P Kaster

1 August 2016 in European Journal of Pharmacology
Verified
Journal Article
Closed access
FKFernanda Neutzling Kaufmann
Fernanda Neutzling Kaufmann
MGMarta Gazal
Marta Gazal
CBClarissa Ribeiro Bastos
Clarissa Ribeiro Bastos
MKManuella P Kaster
Manuella P Kaster
GGGabriele Ghisleni
Gabriele Ghisleni

1 January 2014 in European Psychiatry
Verified
Journal Article
Closed access
CWC. Wiener
C. Wiener
GRG.T. Rassier
G.T. Rassier
MKManuella P Kaster
Manuella P Kaster
KJKaren Jansen
Karen Jansen
RPR.T. Pinheiro
R.T. Pinheiro
RSR.A. da Silva
R.A. da Silva
The present study aimed to determine whether any gender-related difference exists concerning oxidative stress parameters in a population of 231 subjects, and if these changes might be related to gender-associated differences in major depressive disorder (MDD) or bipolar disorder (BD) vulnerability. This is a case-control nested in a population-based study. The initial psychopathology screen was performed with the Mini-International Neuropsychiatric Interview and the diagnostic was further confirmed with the Structured Clinical Interview for DSM-IV. Blood samples were obtained after the interview and the oxidative stress parameters such as uric acid, advanced oxidation protein product (PCC) and lipid hydroperoxides (TBARS) were determined. Our results indicated a higher prevalence of MDD and BD in women when compared to men. In addition, significant gender differences were found in the levels of PCC (0.27 ± 0.27 vs. 0.40 ± 0.31 nmol CO/mg protein, men vs. women, respectively; P = 0.02) and uric acid (4.88 ± 1.39 mg/dL vs. 3.53 ± 1.02 mg/dL, men vs. women, respectively; P = 0.0001), but not in TBARS (0.013 ± 0.01 nmol/mg of protein vs. 0.017 ± 0.02 nmol/mg of protein, men vs. women respectively; P = 0.243). After sample stratification by gender, no association was found between oxidative stress parameters and clinical diagnosis of MDD and BD for women (P = 0.516 for PCC; P = 0.620 for TBARS P = 0.727 for uric acid) and men (P = 0.367 for PCC; P = 0.372 for TBARS P = 0.664 for uric acid). In this study, women seem more susceptible to oxidative stress than male. However, these gender-based differences do not seem to provide a biochemical basis for the epidemiologic differences in mood disorders susceptibility between sexes.

8 September 2013 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
GGGabriela Lorea Godoi
Gabriela Lorea Godoi
LPLisiane de Oliveira Porciúncula
Lisiane de Oliveira Porciúncula
JSJanaína Fagundes Schulz
Janaína Fagundes Schulz
FKFernanda Neutzling Kaufmann
Fernanda Neutzling Kaufmann
João RochaJoão Rocha
João Rocha
HAHiram Larangeira de Almeida
Hiram Larangeira de Almeida

1 September 2014 in Brain Research Bulletin
Verified
Journal Article
Closed access
MGMarta Gazal
Marta Gazal
COCaroline Flach Ortmann
Caroline Flach Ortmann
FMFernanda Amelia Martins
Fernanda Amelia Martins
ESEmilio Luiz Streck
Emilio Luiz Streck
JQJoão Quevedo
João Quevedo
CLClaiton L. Lencina
Claiton L. Lencina